BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28716427)

  • 21. How much phenotypic variation can be attributed to parkin genotype?
    Lohmann E; Periquet M; Bonifati V; Wood NW; De Michele G; Bonnet AM; Fraix V; Broussolle E; Horstink MW; Vidailhet M; Verpillat P; Gasser T; Nicholl D; Teive H; Raskin S; Rascol O; Destée A; Ruberg M; Gasparini F; Meco G; Agid Y; Durr A; Brice A; ;
    Ann Neurol; 2003 Aug; 54(2):176-85. PubMed ID: 12891670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasound-based motion analysis demonstrates bilateral arm hypokinesia during gait in heterozygous PINK1 mutation carriers.
    Nürnberger L; Klein C; Baudrexel S; Roggendorf J; Hildner M; Chen S; Kang JS; Hilker R; Hagenah J
    Mov Disord; 2015 Mar; 30(3):386-92. PubMed ID: 25545816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T313M PINK1 mutation in an extended highly consanguineous Saudi family with early-onset Parkinson disease.
    Chishti MA; Bohlega S; Ahmed M; Loualich A; Carroll P; Sato C; St George-Hyslop P; Westaway D; Rogaeva E
    Arch Neurol; 2006 Oct; 63(10):1483-5. PubMed ID: 17030667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Motor reorganization in asymptomatic carriers of a single mutant Parkin allele: a human model for presymptomatic parkinsonism.
    Buhmann C; Binkofski F; Klein C; Büchel C; van Eimeren T; Erdmann C; Hedrich K; Kasten M; Hagenah J; Deuschl G; Pramstaller PP; Siebner HR
    Brain; 2005 Oct; 128(Pt 10):2281-90. PubMed ID: 15947065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Motor cortical physiology in patients and asymptomatic carriers of parkin gene mutations.
    Schneider SA; Talelli P; Cheeran BJ; Khan NL; Wood NW; Rothwell JC; Bhatia KP
    Mov Disord; 2008 Oct; 23(13):1812-9. PubMed ID: 18759365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson's disease: contribution of automated segmentation neuroimaging method.
    Bilgic B; Bayram A; Arslan AB; Hanagasi H; Dursun B; Gurvit H; Emre M; Lohmann E
    Parkinsonism Relat Disord; 2012 Jun; 18(5):562-6. PubMed ID: 22445249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation.
    Inzelberg R; Hattori N; Mizuno Y
    Neurology; 2005 Dec; 65(11):1843. PubMed ID: 16344545
    [No Abstract]   [Full Text] [Related]  

  • 28. Transcranial sonography findings in a large family with homozygous and heterozygous PINK1 mutations.
    Hagenah JM; Becker B; Brüggemann N; Djarmati A; Lohmann K; Sprenger A; Klein C; Seidel G
    J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1071-4. PubMed ID: 18469032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive and motor function in long-duration PARKIN-associated Parkinson disease.
    Alcalay RN; Caccappolo E; Mejia-Santana H; Tang MX; Rosado L; Orbe Reilly M; Ruiz D; Louis ED; Comella CL; Nance MA; Bressman SB; Scott WK; Tanner CM; Mickel SF; Waters CH; Fahn S; Cote LJ; Frucht SJ; Ford B; Rezak M; Novak KE; Friedman JH; Pfeiffer RF; Marsh L; Hiner B; Payami H; Molho E; Factor SA; Nutt JG; Serrano C; Arroyo M; Ottman R; Pauciulo MW; Nichols WC; Clark LN; Marder KS
    JAMA Neurol; 2014 Jan; 71(1):62-7. PubMed ID: 24190026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.
    Yonova-Doing E; Atadzhanov M; Quadri M; Kelly P; Shawa N; Musonda ST; Simons EJ; Breedveld GJ; Oostra BA; Bonifati V
    Parkinsonism Relat Disord; 2012 Jun; 18(5):567-71. PubMed ID: 22445250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of Leucine-rich repeat kinase 2 (LRRK2) and Parkinson protein 2 (parkin, PARK2) genes mutations in Slovak Parkinson disease patients.
    Bognar C; Baldovic M; Benetin J; Kadasi L; Zatkova A
    Gen Physiol Biophys; 2013 Mar; 32(1):55-66. PubMed ID: 23531835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase of oxidative stress by a novel PINK1 mutation, P209A.
    Chien WL; Lee TR; Hung SY; Kang KH; Wu RM; Lee MJ; Fu WM
    Free Radic Biol Med; 2013 May; 58():160-9. PubMed ID: 23261939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation.
    Khan NL; Scherfler C; Graham E; Bhatia KP; Quinn N; Lees AJ; Brooks DJ; Wood NW; Piccini P
    Neurology; 2005 Jan; 64(1):134-6. PubMed ID: 15642918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marked variation in clinical presentation and age of onset in a family with a heterozygous parkin mutation.
    Tan LC; Tanner CM; Chen R; Chan P; Farrer M; Hardy J; Langston JW
    Mov Disord; 2003 Jul; 18(7):758-63. PubMed ID: 12815654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early-onset Parkinson's disease caused by a novel parkin mutation in a genetic isolate from north-eastern Brazil.
    Chien HF; Rohé CF; Costa MD; Breedveld GJ; Oostra BA; Barbosa ER; Bonifati V
    Neurogenetics; 2006 Mar; 7(1):13-9. PubMed ID: 16328510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism.
    Klein C; Djarmati A; Hedrich K; Schäfer N; Scaglione C; Marchese R; Kock N; Schüle B; Hiller A; Lohnau T; Winkler S; Wiegers K; Hering R; Bauer P; Riess O; Abbruzzese G; Martinelli P; Pramstaller PP
    Eur J Hum Genet; 2005 Sep; 13(9):1086-93. PubMed ID: 15970950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensorimotor integration is abnormal in asymptomatic Parkin mutation carriers: a TMS study.
    Bäumer T; Pramstaller PP; Siebner HR; Schippling S; Hagenah J; Peller M; Gerloff C; Klein C; Münchau A
    Neurology; 2007 Nov; 69(21):1976-81. PubMed ID: 18025391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A 62-year-old woman with early-onset Parkinson's disease associated with the PINKi gene deletion].
    Atsumi M; Li Y; Tomiyama H; Sato K; Hattori N
    Rinsho Shinkeigaku; 2006 Mar; 46(3):199-202. PubMed ID: 16642930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatosensory function in asymptomatic Parkin-mutation carriers.
    Gierthmühlen J; Schumacher S; Deuschl G; Fritzer E; Klein C; Baron R; Helmchen C
    Eur J Neurol; 2010 Mar; 17(3):513-7. PubMed ID: 19863651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features and gene analysis in Korean patients with early-onset Parkinson disease.
    Chung EJ; Ki CS; Lee WY; Kim IS; Kim JY
    Arch Neurol; 2006 Aug; 63(8):1170-4. PubMed ID: 16908747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.